Cargando…
SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232743/ http://dx.doi.org/10.1016/j.jval.2022.04.1682 |
| _version_ | 1784735660206194688 |
|---|---|
| author | Shim, CY Ghani, H Ahmad, L Sharif, H Alikhan, MF Bagol, S Taib, S Tan, CW Ong, XM Wang, LF Han, GF Xiao, Y Song, Y Wei, Y Wong, J Naing, L Cunningham, AC |
| author_facet | Shim, CY Ghani, H Ahmad, L Sharif, H Alikhan, MF Bagol, S Taib, S Tan, CW Ong, XM Wang, LF Han, GF Xiao, Y Song, Y Wei, Y Wong, J Naing, L Cunningham, AC |
| author_sort | Shim, CY |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9232743 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92327432022-06-27 SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population Shim, CY Ghani, H Ahmad, L Sharif, H Alikhan, MF Bagol, S Taib, S Tan, CW Ong, XM Wang, LF Han, GF Xiao, Y Song, Y Wei, Y Wong, J Naing, L Cunningham, AC Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232743/ http://dx.doi.org/10.1016/j.jval.2022.04.1682 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Shim, CY Ghani, H Ahmad, L Sharif, H Alikhan, MF Bagol, S Taib, S Tan, CW Ong, XM Wang, LF Han, GF Xiao, Y Song, Y Wei, Y Wong, J Naing, L Cunningham, AC SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population |
| title | SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population |
| title_full | SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population |
| title_fullStr | SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population |
| title_full_unstemmed | SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population |
| title_short | SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population |
| title_sort | sa16 technology-assisted adaptive recruitment strategy for a national study of immunogenicity of covid-19 vaccines and levels of sars-cov-2 neutralising antibody in the bruneian population |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232743/ http://dx.doi.org/10.1016/j.jval.2022.04.1682 |
| work_keys_str_mv | AT shimcy sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT ghanih sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT ahmadl sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT sharifh sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT alikhanmf sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT bagols sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT taibs sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT tancw sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT ongxm sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT wanglf sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT hangf sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT xiaoy sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT songy sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT weiy sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT wongj sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT naingl sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation AT cunninghamac sa16technologyassistedadaptiverecruitmentstrategyforanationalstudyofimmunogenicityofcovid19vaccinesandlevelsofsarscov2neutralisingantibodyinthebruneianpopulation |